The page is the record's research on the issuer — no analyst, no rating, no view. # ATOSSA THERAPEUTICS, INC. (NASDAQ: ATOS) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is ATOSSA THERAPEUTICS, INC., listed on NASDAQ under ticker ATOS, with ISIN US04962H7044 and LEI 549300QRKP1JTNHD2366. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its listing status is listed, not halted. ## The disclosure read The record holds 39 filings in the twelve months to 2026-11-08, across 25 filing days. The median gap between filing days is 10.0 days. The latest filing is dated 2026-10-09, 30 days before the record date, and is of type corporate_news. The NASDAQ exchange median is 6.0 days for cadence, 52 filings and 5.0 days for latency, against 4359 issuers. The 2834 Pharmaceutical Preparations sector median is 6.0 days for cadence, 63.0 filings and 4.0 days for latency, against 526 issuers. ## Auditor The auditor of record is EY, located in Seattle, Washington. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable, as the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's investor-relations page names 2 research houses: Maxim Group, LLC and Ascendiant Capital. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 10 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001488039.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/ATOS (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1488039/000119312526124396/atos-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://investors.atossatherapeutics.com/ir-resources/faqs (coverage) - https://mcp.us-cm-kg.ai/record/NASDAQ/ATOS (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ATOS · public-record only · the same page signed and receipted: get_research at https://mcp.getissuer.ai/mcp